The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD

Who May Qualify: - All patients aged 18 years or older with Crohn's disease who undergo resection with an endoscopically accessible primary anastomosis which results in macroscopic normality. - Patients having a reversal of a temporary ileostomy created after previous surgery for Crohn's disease may be enrolled provided that the reversal of the ileostomy results in a primary anastomosis and macroscopic normality of the remaining bowel. - Patients with co-existing perianal disease may be included provided the resection has led to a primary anastomosis and macroscopic normality of the intestine. - Patients must have proven history of Crohn's disease based on (clinical, radiologic, endoscopic and histologic criteria). Who Should NOT Join This Trial: - Patients with anastomosis which is endoscopically inaccessible by standard colonoscopy. - Patients in whom there is persisting macroscopic abnormality post-surgical resection. - Patients with Crohn's disease who have an end stoma (ileostomy or colostomy). - Patients for whom endoscopy is not suitable due to co-morbidities or unwell clinical state - Inability to give willing to sign a consent form. - Inability to obtain access to the anastomosis at colonoscopy. - Suspected perforation of the gastrointestinal tract. - Patients who are pregnant or breastfeeding. Always talk to your doctor about whether this trial is right for you.